Style de citation APA (7e éd.)

SJ, Z., DH, W., YW, L., L, H., X, X., M, M., . . . Y, M. (2017). A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects. Dove Medical Press.

Style de citation Chicago (17e éd.)

SJ, Zhao, Wang DH, Li YW, Han L, Xiao X, Ma M, Wan DC, Hong A, et Ma Y. A Novel Selective VPAC2 Agonist Peptide-conjugated Chitosan Modified Selenium Nanoparticles with Enhanced Anti-type 2 Diabetes Synergy Effects. Dove Medical Press, 2017.

Style de citation MLA (8e éd.)

SJ, Zhao, et al. A Novel Selective VPAC2 Agonist Peptide-conjugated Chitosan Modified Selenium Nanoparticles with Enhanced Anti-type 2 Diabetes Synergy Effects. Dove Medical Press, 2017.